Friday, 28 January 2022
DCGI approves Bharat Biotech's intranasal booster dose trials
The Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for intranasal booster dose trials in India. The trials will be done at nine different sites.
from Times of India https://timesofindia.indiatimes.com/india/dcgi-approves-bharat-biotechs-intranasal-booster-dose-trials-in-india/articleshow/89176728.cms
from Times of India https://timesofindia.indiatimes.com/india/dcgi-approves-bharat-biotechs-intranasal-booster-dose-trials-in-india/articleshow/89176728.cms
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment